Dosimetric Comparison Between 2-Dimensional Radiation Therapy and Intensity Modulated Radiation Therapy in Treatment of Advanced T-Stage Nasopharyngeal Carcinoma: To Treat Less or More in the Planning Organ-At-Risk Volume of the Brainstem and Spinal Cord

Ho, 1982, Nasopharynx, 24 Ho, 1978, An epidemiological and clinical study of nasopharyngeal carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 4, 183, 10.1016/0360-3016(78)90137-2 Teo, 1989, A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong, Int. J. Radiat. Oncol. Biol. Phys., 17, 515, 10.1016/0360-3016(89)90102-8 Lee, 1992, Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failure, Int. J. Radiat. Oncol. Biol. Phys., 23, 261, 10.1016/0360-3016(92)90740-9 Teo, 1996, Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography, Int. J. Radiat. Oncol. Biol. Phys., 36, 291, 10.1016/S0360-3016(96)00323-9 Lee, 2005, Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong Experience, Int. J. Radiat. Oncol. Biol. Phys., 61, 1107, 10.1016/j.ijrobp.2004.07.702 Kam, 2003, Intensity-modulated radiotherapy in nasopharyngeal carcinoma: Dosimetric advantage over conventional plans and feasibility of dose escalation, Int. J. Radiat. Oncol. Biol. Phys., 56, 145, 10.1016/S0360-3016(03)00075-0 Hunt, 2001, Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer, Int. J. Radiat. Oncol. Biol. Phys., 49, 623, 10.1016/S0360-3016(00)01389-4 Zhou, 2003, Potential of intensity-modulated radiotherapy to escalate doses to head-and-neck cancers: What is the maximal dose?, Int. J. Radiat. Oncol. Biol. Phys., 57, 673, 10.1016/S0360-3016(03)00626-6 Sultanem, 2000, Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The University of California-San Francisco experience, Int. J. Radiat. Oncol. Biol. Phys., 48, 711, 10.1016/S0360-3016(00)00702-1 1999, ICRU Report 62 Cheng, 2001, Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma, Int. J. Cancer, 96, 126, 10.1002/ijc.1004 Lee, 2002, Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience, Int. J. Radiat. Oncol. Biol. Phys., 53, 12, 10.1016/S0360-3016(02)02724-4 Xia, 2000, Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 48, 329, 10.1016/S0360-3016(00)00585-X Chao, 2000, Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience, Int. J. Cancer, 90, 92, 10.1002/(SICI)1097-0215(20000420)90:2<92::AID-IJC5>3.0.CO;2-9 Chau, 2001, Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma, Radiother. Oncol., 58, 143, 10.1016/S0167-8140(00)00336-4 1997 Wong, 2003, The use of anchoring bite system in NPC treatment setup, J. H.K. Coll. Radiol. Suppl., 6, 127 Niemierko, 1993, Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor, Radiother. Oncol., 29, 140, 10.1016/0167-8140(93)90239-5 Webb, 1993, A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and colongenic cell density, Phys. Med. Biol., 38, 653, 10.1088/0031-9155/38/6/001 Burman, 1991, Fitting of normal tissue tolerance data to an analytic function, Int. J. Radiat. Oncol. Biol. Phys., 21, 123, 10.1016/0360-3016(91)90172-Z Lyman, 1987, Optimization of radiation therapy, III: A method of assessing complication probability from dose-volume histograms, Int. J. Radiat. Oncol. Biol. Phys., 13, 103, 10.1016/0360-3016(87)90266-5 Sanchez-Nieto, 1999, The Delta Concept: A clinically useful measure of tumor control probabilty, Int. J. Radiat. Oncol. Biol. Phys., 44, 369, 10.1016/S0360-3016(99)00029-2 Emami, 1991, Tolerance of normal tissue to therapeutic radiation, Int. J. Radiat. Oncol. Biol. Phys., 16, 1623 Raaijmakers, 2002, Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation?, Radiother. Oncol., 65, 1, 10.1016/S0167-8140(02)00211-6 Honore, 2002, Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: Individualized risk-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 53, 638, 10.1016/S0360-3016(02)02760-8 Eisbruch, 1999, Dose, volume and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer, Int. J. Radiat. Oncol. Biol. Phys., 45, 577, 10.1016/S0360-3016(99)00247-3 Chao, 2001, A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: Initial results, Int. J. Radiat. Oncol. Biol. Phys., 49, 907, 10.1016/S0360-3016(00)01441-3 Kam, 2004, Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong Experience, Int. J. Radiat. Oncol. Biol. Phys., 60, 1440, 10.1016/j.ijrobp.2004.05.022 Purdy, 2002, Dose-volume specification: New challenges with intensity modulated radiation therapy, Semin. Radiat. Oncol., 12, 199, 10.1053/srao.2002.32432